Evidence map›Paper›PMID 31634346›Full record

ArticlePloS one2019

Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.

Maria Pia Amato, Elio Prestipino, Angelo Bellinvia, Claudia Niccolai, Lorenzo Razzolini, Luisa Pastò, Roberto Fratangelo, Laura Tudisco, Mattia Fonderico, Paolo Luca Mattiolo and 5 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05546424 (EMRESERVA A Program to Enhace Cognitive Reserve in Patients With Multiple Scleorisis), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05546424 completednot on this mapstarted 2022, after this paper: background citation

EMRESERVA A Program to Enhace Cognitive Reserve in Patients With Multiple Scleorisis

TypeobservationalSponsorFundación Pública Andaluza para la gestión de la Investigación en SevillaRan2022 to 2023Enrolled58ConditionsCognitive ChangeArmsEMRESERVA
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Cultural Adaptation and Validation of the CALMS Questionnaire in an Arabic-Speaking MS Population.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026
    Article
  5. Article
  6. Article
  7. Observational
  8. Observational
  9. Article
  10. Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Maria Pia AmatoDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.ORCID 0000-0003-3325-3760
Elio PrestipinoDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Angelo BellinviaDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.ORCID 0000-0001-9889-9058
Claudia NiccolaiDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Lorenzo RazzoliniDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Luisa PastòSOD Neurological Rehabilitation, Careggi University Hospital, Florence, Italy.
Roberto FratangeloDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Laura TudiscoDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Mattia FondericoDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Paolo Luca MattioloDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Benedetta GorettiDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
Giovanni Bosco ZimatoreOperative Unit of Neurology, Dimiccoli General Hospital, Barletta, Italy.
Nunzia Alessandra LosignoreOperative Unit of Neurology, Dimiccoli General Hospital, Barletta, Italy.
Emilio PortaccioSOC Neurology, San Giovanni di Dio Hospital, Florence, Italy.
Francesco LolliDepartment NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany potentially modifiable risk factors for MS are investigated. It is not known, however, if these factors also apply to MS-related cognitive impairment (CI), a frequent consequence of MS.

objectiveThe aim of our study was to assess risk factors for CI in MS patients, focusing on environmental exposures, lifestyle and comorbidities.

methodsWe included MS patients referring to MS Centers in Florence and Barletta between 2014 and 2017. Neuropsychological performance was assessed through the Rao's battery and Stroop test, cognitive reserve (premorbid intelligence quotient-IQ) was evaluated using the National Adult Reading Test (NART). Potential risk factors were investigated through a semi-structured questionnaire.

results150 patients were included. CI was detected in 45 (30%) subjects and was associated with older age (p<0.005), older age at MS onset (p = 0.016), higher EDSS score (p<0.005), progressive disease course (p = 0.048) and lower premorbid IQ score (p<0.005). As for risk factors, CI was related with lower physical activity in childhood-adolescence (p<0.005). In women, hormonal therapy resulted to be protective against CI (p = 0.041). However, in the multivariable analysis, the only significant predictors of CI were older age (p<0.05; OR 1.06, 95% CI 1.02-1.10) and lower premorbid IQ (p<0.05; OR 0.93, 95% CI: 0.88-0.98). Removing IQ from the model, CI was associated with higher EDSS (p = 0.030; OR 1.25, 95% CI 1.02-1.53) and, marginally, previous physical activity (p = 0.066; OR 0.49, 95% CI: 0.23-1.05).

conclusionsOur findings suggest that physical activity in childhood-adolescence could be a contributor to cognitive reserve building, thus representing a potential protective factors for MS-related CI susceptible to preventive strategies.

Indexed as

AdultCannabisCognitive DysfunctionCognitive ReserveDisease ProgressionExerciseFemaleHumansIntelligence TestsLife StyleMaleMiddle AgedMultiple SclerosisNeuropsychological TestsRisk FactorsSmoking

Identifiers

PMID31634346
PMCPMC6802833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.